RA Capital Management - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 63 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$6,355,649
-12.8%
1,088,2960.0%0.13%
-17.3%
Q3 2022$7,292,000
-47.6%
1,088,296
-67.1%
0.16%
-58.0%
Q2 2022$13,923,000
+36.2%
3,307,203
+9.0%
0.37%
+66.4%
Q1 2022$10,223,000
+7.0%
3,033,6030.0%0.22%
+32.7%
Q4 2021$9,556,000
-3.7%
3,033,6030.0%0.17%
+22.6%
Q3 2021$9,920,000
-22.5%
3,033,6030.0%0.14%
-33.2%
Q2 2021$12,802,000
-15.4%
3,033,6030.0%0.20%
-10.1%
Q1 2021$15,138,000
-34.3%
3,033,603
+66.4%
0.23%
-29.2%
Q4 2020$23,049,000
+26.3%
1,823,520
-1.9%
0.32%
-3.6%
Q3 2020$18,250,000
-1.3%
1,858,4740.0%0.33%
-7.2%
Q2 2020$18,492,000
+12.6%
1,858,4740.0%0.36%
-30.6%
Q1 2020$16,429,000
+65.1%
1,858,474
+178.0%
0.52%
-48.2%
Q2 2015$9,953,000
-0.4%
668,406
+1.3%
1.00%
+0.8%
Q1 2015$9,996,000660,0000.99%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CONCERT PHARMACEUTICALS INC shareholders